162 related articles for article (PubMed ID: 15125920)
1. Novel 3,5-diaryl pyrazolines as human acyl-CoA:cholesterol acyltransferase inhibitors.
Jeong TS; Kim KS; An S; Cho KH; Lee S; Lee WS
Bioorg Med Chem Lett; 2004 Jun; 14(11):2715-7. PubMed ID: 15125920
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of acyl CoA:cholesterol acyltransferase.
Vaccaro W; Amore C; Berger J; Burrier R; Clader J; Davis H; Domalski M; Fevig T; Salisbury B; Sher R
J Med Chem; 1996 Apr; 39(8):1704-19. PubMed ID: 8648610
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationship studies on a novel series of naphthylidinoylureas as inhibitors of acyl-CoA:cholesterol O-acyltransferase (ACAT).
Ohnuma S; Muraoka M; Ioriya K; Ohashi N
Bioorg Med Chem Lett; 2004 Mar; 14(5):1309-11. PubMed ID: 14980688
[TBL] [Abstract][Full Text] [Related]
4. Saucerneol B derivatives as human acyl-CoA: cholesterol acyltransferase inhibitors.
Jeong TS; Kim KS; Yu H; Kim MJ; Cho KH; Choi YK; Kim HC; Park HY; Lee WS
Bioorg Med Chem Lett; 2005 Jan; 15(2):385-8. PubMed ID: 15603959
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of novel 4,5-diphenylthiazole derivatives as potential acyl-CoA:cholesterol O-acyltransferase inhibitors.
Romeo G; Salerno L; Milla P; Siracusa M; Cattel L; Russo F
Pharmazie; 1999 Jan; 54(1):19-23. PubMed ID: 9987793
[TBL] [Abstract][Full Text] [Related]
6. Potent inhibitors of acyl-CoA:cholesterol acyltransferase. 2. Structure-activity relationships of novel N-(2,2-dimethyl-2,3-dihydrobenzofuran-7-yl)amides.
Kataoka K; Shiota T; Takeyasu T; Minoshima T; Watanabe K; Tanaka H; Mochizuki T; Taneda K; Ota M; Tanabe H; Yamaguchi H
J Med Chem; 1996 Mar; 39(6):1262-70. PubMed ID: 8632433
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: part 1.
Ohtawa M; Yamazaki H; Ohte S; Matsuda D; Ohshiro T; Rudel LL; Omura S; Tomoda H; Nagamitsu T
Bioorg Med Chem Lett; 2013 Mar; 23(5):1285-7. PubMed ID: 23369538
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of acyl-CoA:cholesterol O-acyltransferase. 2. Identification and structure-activity relationships of a novel series of N-alkyl-N-(heteroaryl-substituted benzyl)-N'-arylureas.
Tanaka A; Terasawa T; Hagihara H; Sakuma Y; Ishibe N; Sawada M; Takasugi H; Tanaka H
J Med Chem; 1998 Jun; 41(13):2390-410. PubMed ID: 9632372
[TBL] [Abstract][Full Text] [Related]
9. Selectivity of pyripyropene derivatives in inhibition toward acyl-CoA:cholesterol acyltransferase 2 isozyme.
Ohshiro T; Ohte S; Matsuda D; Ohtawa M; Nagamitsu T; Sunazuka T; Harigaya Y; Rudel LL; Omura S; Tomoda H
J Antibiot (Tokyo); 2008 Aug; 61(8):503-8. PubMed ID: 18997389
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: part 2.
Ohtawa M; Yamazaki H; Matsuda D; Ohshiro T; Rudel LL; Ōmura S; Tomoda H; Nagamitsu T
Bioorg Med Chem Lett; 2013 May; 23(9):2659-62. PubMed ID: 23535327
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activity of novel 4-phenyl-1,8-naphthyridin-2(1H)-on-3-yl ureas: potent acyl-CoA:cholesterol acyltransferase inhibitor with improved aqueous solubility.
Ban H; Muraoka M; Ioriya K; Ohashi N
Bioorg Med Chem Lett; 2006 Jan; 16(1):44-8. PubMed ID: 16242323
[TBL] [Abstract][Full Text] [Related]
12. Biphenyl versus phenylpyridazine derivatives: the role of the heterocycle in a series of acyl-CoA:cholesterol acyl transferase inhibitors.
Gelain A; Barlocco D; Kwon BM; Jeong TS; Im KR; Legnani L; Toma L
J Med Chem; 2008 Mar; 51(5):1474-7. PubMed ID: 18284184
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, X-ray crystal structure, and biological activity of FR186054, a novel, potent, orally active inhibitor of acyl-CoA:cholesterol O-acyltransferase (ACAT) bearing a pyrazole ring.
Tanaka A; Terasawa T; Hagihara H; Kinoshita T; Sakuma Y; Ishibe N; Sawada M; Takasugi H; Tanaka H
Bioorg Med Chem Lett; 1998 Jan; 8(1):81-6. PubMed ID: 9871633
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological profile of SMP-797, a novel acyl-coenzyme a: cholesterol acyltransferase inhibitor with inducible effect on the expression of low-density lipoprotein receptor.
Ioriya K; Kino K; Horisawa S; Nishimura T; Muraoka M; Noguchi T; Ohashi N
J Cardiovasc Pharmacol; 2006 Feb; 47(2):322-9. PubMed ID: 16495773
[TBL] [Abstract][Full Text] [Related]
15. Chemical modification and structure-activity relationships of pyripyropenes. 3. Synthetic conversion of pyridine-pyrone moiety.
Obata R; Sunazuka T; Tian Z; Tomoda H; Harigaya Y; Omura S
J Antibiot (Tokyo); 1997 Mar; 50(3):229-36. PubMed ID: 9127194
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: part 3.
Ohtawa M; Yamazaki H; Ohte S; Matsuda D; Ohshiro T; Rudel LL; Ōmura S; Tomoda H; Nagamitsu T
Bioorg Med Chem Lett; 2013 Jul; 23(13):3798-801. PubMed ID: 23711919
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of unprecedented classes of spiro-beta-lactams and azido-beta-lactams as acyl-CoA:cholesterol acyltransferase inhibitors.
Benfatti F; Cardillo G; Gentilucci L; Tolomelli A
Bioorg Med Chem Lett; 2007 Apr; 17(7):1946-50. PubMed ID: 17275297
[TBL] [Abstract][Full Text] [Related]
18. Human ACAT inhibitory effects of shikonin derivatives from Lithospermum erythrorhizon.
An S; Park YD; Paik YK; Jeong TS; Lee WS
Bioorg Med Chem Lett; 2007 Feb; 17(4):1112-6. PubMed ID: 17157006
[TBL] [Abstract][Full Text] [Related]
19. Heterocyclic ureas: inhibitors of acyl-CoA:cholesterol O-acyltransferase as hypocholesterolemic agents.
White AD; Creswell MW; Chucholowski AW; Blankley CJ; Wilson MW; Bousley RF; Essenburg AD; Hamelehle KL; Krause BR; Stanfield RL; Dominick MA; Neub M
J Med Chem; 1996 Oct; 39(22):4382-95. PubMed ID: 8893833
[TBL] [Abstract][Full Text] [Related]
20. Isoform-specific inhibitors of ACATs: recent advances and promising developments.
Ohshiro T; Tomoda H
Future Med Chem; 2011 Dec; 3(16):2039-61. PubMed ID: 22098352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
